GlassScriptPhysician profile
Hayden D Henry
NPI 1639133580
$8,912.98
in general payments reported to CMS, 2019-2025
49 companies · $826 in 2025
The $826 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,354 · 2020: $911 · 2021: $1,239 · 2022: $798 · 2023: $2,529 · 2024: $1,256 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,558 · Travel and Lodging: $1,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,557.52 |
| Travel and Lodging | $1,053.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,431.72 | 2023-2025 | Aquabeam Robotic System |
| Astellas Pharma US INC | $1,146.64 | 2019-2025 | Xtandi |
| Myriad Genetic Laboratories, INC. | $1,054.91 | 2020-2025 | Prolaris, Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $651.21 | 2021-2025 | |
| Coloplast Corp | $614.74 | 2019-2025 | Altis |
| Pfizer INC. | $465.57 | 2019-2025 | |
| Verity Pharmaceuticals INC. | $398.40 | 2021-2025 | Trelstar |
| Medtronic, INC. | $382.87 | 2021-2025 | Interstim |
| Abbvie INC. | $342.35 | 2019-2025 | |
| Boston Scientific Corporation | $274.59 | 2019-2023 | Rezum Generator |
| Sumitomo Pharma America, INC. | $206.04 | 2023-2024 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $179.33 | 2019-2022 | |
| Neotract INC. | $155.73 | 2019-2020 | |
| Valencia Technologies Corporation | $149.04 | 2024 | Ecoin Device Kit |
| Intuitive Surgical, INC. | $137.04 | 2019 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $105.72 | 2020-2024 | Xyosted, Nocdurna, Tlando |
| Endo Pharmaceuticals INC. | $95.21 | 2019-2024 | Xiaflex, Aveed |
| Urovant Sciences INC | $82.38 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $77.09 | 2021-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Teleflex LLC | $77.06 | 2021-2024 | Urolift |
| Ferring Pharmaceuticals INC. | $70.92 | 2024-2025 | Adstiladrin |
| Kerecis Limited | $65.62 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bk Medical Holding Company INC. | $65.38 | 2023 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Janssen Scientific Affairs, LLC | $63.52 | 2019 | |
| Myovant Sciences INC. | $62.96 | 2022 | |
| Axonics, INC. | $52.61 | 2020-2022 | |
| Tolmar Pharmaceuticals, INC. | $50.85 | 2019-2022 | |
| Healthtronics Stone Solutions, LLC | $41.15 | 2019 | |
| Olympus America INC. | $40.38 | 2022-2025 | Itind System |
| Genzyme Corporation | $36.20 | 2019-2020 | |
| Clarus Therapeutics INC. | $36.07 | 2021 | |
| Caldera Medical, INC | $29.47 | 2021-2023 | Desara |
| Sagent Pharmaceuticals | $22.50 | 2021 | |
| Endo USA, INC. | $22.26 | 2024 | Xiaflex |
| Tolmar, INC. | $20.80 | 2024 | |
| Civco Medical Instruments | $17.86 | 2025 | |
| Accord Healthcare, INC. | $17.56 | 2025 | |
| Blue Earth Diagnostics | $17.51 | 2019 | |
| Lumenis, INC | $17.07 | 2021 | |
| Medtronic USA, INC. | $16.52 | 2020 | |
| Covidien LP | $16.26 | 2019 | |
| Urogen Pharma, INC. | $14.60 | 2023 | Jelmyto |
| Photocure INC | $14.17 | 2020 | |
| Travere Therapeutics, INC. | $13.47 | 2020 | |
| Hollister Incorporated | $12.40 | 2022 | |
| Allegis Pharmaceuticals, LLC | $12.05 | 2023 | Urimar-T Caps |
| Allergan, INC. | $11.97 | 2020 | |
| Cook Medical LLC | $11.96 | 2021 | |
| Zyla Life Sciences, INC. | $11.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hayden Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.